What question did this study set out to answer?

Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study

View Full Paper

Ask AI

Bookmark

Authors

Real-world study demonstrates high effectiveness and good safety of guselkumab in adult patients with psoriasis, implying treatment promise.

To assess the effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis.
Conducted a multicentric study in Italy
Followed adult patients with facial and/or genital psoriasis
Evaluated treatment effects over 52 weeks
Guselkumab showed high effectiveness in reducing psoriasis symptoms
A good safety profile was observed during the treatment period

Bonifati et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Real-world study demonstrates high effectiveness and good safety of guselkumab in adult patients with psoriasis, implying treatment promise.